Even so, it racked up almost $700m of sales (at far less per jab, because it is sold at cost) in the latest quarter. Moderna is projecting $19bn of sales for its vaccine in 2021, and while we are never likely to get accurate numbers for the Russian and…

Click here to view the original article.